Arineta Cardio Imaging Installs First SpotLight Scanner in the US, Improving National Access to Cardiac Imaging

Led by its new CEO, Arineta’s SpotLight scanner was deployed in its  first cardiology practice in the US, decreasing time patients must wait for imaging results and improving access to cutting edge technology

Caesarea, Israel – December 14, 2023 – Arineta Cardio Imaging, a leader in advancing cardiovascular imaging solutions through cutting-edge technology, installed its first SpotLight scanner in the U.S. at Connected Cardiovascular Care Associates (C3) in Dallas. Arineta ushers in this milestone along with the appointment of its new CEO, Douglas Ryan.

Ryan brings 30 years of experience creating business infrastructure and crafting market strategies for medical device companies to Arineta. Ryan comes from Siemens Healthineers as Vice President of their Computed Tomography Business Line. 

“I am extremely proud to be joining this global team improving the standards and accessibility of cardiac CT,” said Ryan. “Moving forward, we will expand upon the momentum already driving Arineta to supply innovative, affordable dedicated cardio-thoracic CT solutions.”

The 510k FDA cleared SpotLight is a single beat, whole heart scanner optimized with 140 mm coverage at a rotation speed of 0.24 sec per rotation. As the first dedicated cardiovascular CT scanner designed to provide comprehensive clinical information for diagnosis and therapy planning, it allows cardiology practices to quickly and efficiently image their patients. 

C3 is the first practice to install the SpotLight scanner in the US. Tony Das, MD, founder and CEO of C3, has seen a profound impact on his practice since its implementation. 

“Cardiac CT is the Level 1A test for diagnosis of stable and acute chest pain by the American College of Cardiology (ACC) and American Heart Association (AHA),” said Dr. Das. “Typically, patients must face long wait times in scheduling their appointment and are often referred out to expensive hospitals or imaging centers. With Arineta’s SpotLight, we can now provide them answers in just days instead of weeks .”

To help alleviate the backlog of Dallas imaging centers, C3 will allow area doctors to image their patients at its facility using the SpotLight, improving access and affordability of cardiac imaging, not only for its own patients, but for those of other providers as well. 

For more information, visit arineta.com.

About Arineta

Arineta Cardio Imaging is an Israeli company that develops and produces innovative cardiovascular imaging solutions. It is dedicated to growing cardiac CT as the front-line non-invasive test for diagnosing, therapy planning and monitoring of cardiovascular disease, the no. 1 cause of death and costs for healthcare worldwide. Arineta’s flagship product, SpotLight™ Duo, is the world’s first dedicated single-heartbeat, whole-heart cardiovascular and thoracic CT, based on the company’s proprietary Stereo CT technology. The company is part of a long tradition of medical imaging innovation that began in Israel in the 1970s. Among Arineta’s scientists are the inventors of the multi-slice spiral CT technology, still the cornerstone of CT imaging, and several other key technologies.

For more information, visit arineta.com.